Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Pfizer Limited    500680   INE182A01018

PFIZER LIMITED

(500680)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mumbai Stock Exchange
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
4992.35 4997.55 5013.05 5062.1 5112.85 Last
1195 1640 1328 3211 4684 Volume
+0.43% +0.10% +0.31% +0.98% +1.00% Change
Financials
Sales 2021 22 690 M 307 M 307 M
Net income 2021 5 704 M 77,2 M 77,2 M
Net Debt 2021 - - -
P/E ratio 2021 41,0x
Yield 2021 6,32%
Sales 2022 25 328 M 343 M 343 M
Net income 2022 6 128 M 83,0 M 83,0 M
Net Debt 2022 - - -
P/E ratio 2022 38,2x
Yield 2022 0,61%
Capitalization 234 B 3 168 M 3 166 M
Capi. / Sales 2021 10,3x
Capi. / Sales 2022 9,23x
Nbr of Employees 2 489
Free-Float 34,0%
More Financials
Company
Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for Anti-Allergic, Anti-Diabetic, Antihistamine, Anti-Infectives, Cardiovascular, Dermatology, Erectile Dysfunction,... 
Sector
Pharmaceuticals
Calendar
11/17Earnings Release
More about the company
Notations Surperformance© of Pfizer Limited
Trading Rating : Investor Rating :
More Ratings
All news about PFIZER LIMITED
12:49pWhy Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase
DJ
12:17pCanada to invest up to C$214 mln for research into domestic-made vaccines - P..
RE
10/22Germany readies for coronavirus vaccine before end of year -Bild
RE
10/22Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a..
RE
10/22NEWS HIGHLIGHTS : Top Company News of the Day
DJ
10/22Britain partners with Oxford firm to assess coronavirus vaccine T cell respon..
RE
10/21Health Care Down On Stimulus, Vaccine Doubts -- Health Care Roundup
DJ
10/21Ecuador signs COVID-19 vaccine supply deals with pharma companies
RE
10/21Covid-19 Vaccines to Be Stored Secretly Under Tight Security
DJ
10/21Pfizer Sets Up Its 'Biggest Ever' Vaccination Distribution Campaign
DJ
10/20EXCLUSIVE : U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - so..
RE
10/20EXCLUSIVE : U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - so..
RE
10/20Mexico could share some COVID-19 vaccine liabilities with laboratories
RE
10/20Mexico could absorb some COVID-19 vaccine liabilities
RE
10/19Global equities decline on COVID lockdown fears
RE
More news
News in other languages on PFIZER LIMITED
04:25pCORONAVIRUS : l'essai clinique du vaccin AstraZeneca/Oxford a repris aux USA
02:05pCOVID-19 : le Canada annonce un accord pour un vaccin canadien
01:18pEUROPE : Corr Les marchés européens rattrapent un peu leur semaine
12:10pSTOCK MARKET PARIS : Paris termine la semaine sur une bonne note
07:30aSTOCK MARKET PARIS : Paris grimpe, misant sur un apaisement des craintes sanitai..
More news
Analyst Recommendations on PFIZER LIMITED
More recommendations
Chart PFIZER LIMITED
Duration : Period :
Pfizer Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 5 112,85 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Sridhar Subramaniam Managing Director & Executive Director
Rajendra Ambalal Shah Chairman
Deepak Rakheja Director-Global Commercial Operations
Milind Patil Chief Financial Officer & Executive Director
Navin Singhania Director-Business Technology
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER LIMITED21.04%3 144
JOHNSON & JOHNSON-0.54%381 970
ROCHE HOLDING AG-5.33%280 343
PFIZER INC.-4.47%207 994
MERCK & CO., INC.-12.91%200 341
NOVARTIS AG-16.62%186 175